Medical Device Investing AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medical Device Investing Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
Medical Device Investing NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy
Medical Device Investing Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth
Medical Device Investing Republic Technologies Doubles ETH Holdings Amid 23% Appreciation in Total Value
Medical Device Investing Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse Technology
Medical Device Investing NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy
Medical Device Investing Republic Technologies Announces Drawdown of US$10 Million Principal Amount First Tranche Under US$100 Million Secured Convertible Note Facility
Medical Device Investing Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
Medical Device Investing Medtronic announces FDA clearance of Hugo robotic-assisted surgery system for urologic surgical procedures
